XLY — Auxly Cannabis Cashflow Statement
0.000.00%
- CA$111.76m
- CA$161.74m
- CA$122.33m
- 63
- 84
- 89
- 93
Annual cashflow statement for Auxly Cannabis, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -87.4 | -45.9 | -130 | -44.5 | -16.3 |
Depreciation | |||||
Non-Cash Items | 43.5 | 11.7 | 86.2 | 23.7 | 22.9 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.4 | -29.7 | 20 | 17.9 | -0.054 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -33.1 | -49.6 | -2.48 | 8.21 | 16.8 |
Capital Expenditures | -20.7 | -0.378 | -9.19 | -1.6 | -2.76 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 6.2 | 17.7 | 10.4 | 0.047 | 2.32 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -14.5 | 17.3 | 1.18 | -1.56 | -0.445 |
Financing Cash Flow Items | — | -0.197 | 0 | -0.431 | -0.612 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 24.7 | 26.4 | 1.18 | -5.68 | -13.6 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -22.9 | -5.9 | -0.118 | 0.972 | 2.75 |